New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
08:28 EDTRGDORegado Biosciences raises $20M in a private placement
Under the agreement, the investors will purchase an aggregate of 4 million shares of common stock at a purchase price of $5.00 per share. The net proceeds of the offering are expected to be used for general corporate and working capital purposes, including the ongoing Phase 3 REGULATE-PCI clinical trial. Cowen and Company acted as the lead placement agent for the offering, and BMO Capital Markets acted as co-placement agent.
News For RGDO From The Last 14 Days
Check below for free stories on RGDO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 11, 2014
12:00 EDTRGDORegado Biosciences falls 15.8%
Subscribe for More Information
10:00 EDTRGDORegado Biosciences falls 17.6%
Subscribe for More Information
09:00 EDTRGDORegado Biosciences falls 16.3%
Subscribe for More Information
07:34 EDTRGDORegado Biosciences 10M share Secondary priced at $6.00
Jefferies, Deutsche Bank and Cowen acted as joint book running managers for the offering.
April 10, 2014
12:00 EDTRGDORegado Biosciences falls 13.3%
Subscribe for More Information
10:00 EDTRGDORegado Biosciences falls 8.1%
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use